FSA Wealth Management’s iShares Biotechnology ETF IBB Stock Holding History

FSA Wealth Management’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$64.6K	Hold	447	–	–	0.02%	139
2025 Q2	$56.6K	Hold	447	–	–	0.02%	143
2025 Q1	$57.2K	Hold	447	–	–	0.02%	142
2024 Q4	$59.1K	Hold	447	–	–	0.02%	136
2024 Q3	$65.1K	Buy	+447	New	+$64.7K	0.03%	131
2024 Q1	$61.3K	Hold	447	–	–	0.03%	130
2023 Q4	$61K	Buy	+447	New	+$54.5K	0.03%	118
2020 Q2	–	Sell	-300	Closed	-$32K	–	401
2020 Q1	$32K	Sell	300 -200	-40%	-$23K	0.03%	134
2019 Q4	$60K	Buy	+500	New	+$55.8K	0.04%	114

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

FSA Wealth Management's IBB Position: Q3 2025 in Review

FSA Wealth Management held its iShares Biotechnology ETF (IBB) position steady in Q3 2025 at 447 shares worth $64.6K. The position accounts for 0.02% of the portfolio, ranked #139.

FSA Wealth Management first reported a position in IBB in Q4 2019 and has held it in 9 quarters since. The position peaked at $65.1K in Q3 2024. 803 funds tracked by Wall St. Rank hold IBB as of Q3 2025.

FSA Wealth Management held 447 shares of iShares Biotechnology ETF worth $64.6K as of Q3 2025.
FSA Wealth Management left its iShares Biotechnology ETF share count unchanged in Q3 2025.
iShares Biotechnology ETF made up 0.02% of FSA Wealth Management's portfolio in Q3 2025, its #139 holding.
FSA Wealth Management first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 9 quarters since.
FSA Wealth Management's iShares Biotechnology ETF position peaked at $65.1K in Q3 2024.
803 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.